Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus azithromycin vs hydroxychloroquine in hospitalized COVID-19 patients
2020-001406-27Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine monotherapy with Hydroxychloroquine plus azithromycin (2 arms). Started Apr 2020; status: terminated.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001406-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001406-27.